2017 Patient Symposium

Friday, October 27, 2017 - 10:00am to 3:00pm EST

The ILD Collaborative is proud to host:  


Friday, October 27, 2017


Participation is encouraged by all people impacted by IPF regardless of where their healthcare is provided.

Parking, a light breakfast and lunch will be provided complimentary for attendees.

Please click on the titles of the talks to view the slides. 


9:00am - 10:00am
Check-in and Light Breakfast 

10:00am - 10:15am
Welcome and Opening Remarks
Dr. Peter LaCamera, SEMC
Dr. Aliaa Barakat, ILD Collaborative
Dr. Rachel Knipe, MGH

10:15am - 10:45am
Drugs for IPF Part 1: Pirfenidone
Dr. Joseph Zibrak, BIDMC
Drugs for IPF Part 2: Nintedanib
Dr. Rob Hallowell, BIDMC
Medications Side Effect Management

10:45am - 11:05am
IPF Co-morbidities and What Can be Done for Them?
Dr. Sydney Montesi, MGH

11:05am - 11:20am
Genomics and IPF
Dr. John Tedrow, SEMC

11:20am - 11:40am
New Directions for IPF Treatments: Update on Clinical Trials
Dr. Barry Shea, RIH

11:40am - 12:00pm
Audience Questions

12:00pm - 1:00pm
Lunch Social (Main Room)

12:20pm - 12:55pm
Discussion Sessions 
Room 1: Lung Transplantation for IPF 
Dr. Todd Astor, MGH
Room 2: Palliative Care and IPF
Dr. Jessica McCannon, MGH

1:00pm - 1:20pm
The Importance of Exercise and Oxygen in IPF
Dr. Fiona Gibbons, MGH
Nancy Davis, RRT, MGH
Abby Folger, PT, DPT, MGH
Jessica Garton, PT, DPT, MGH

1:20pm - 2:05pm
Talking About What Matters: 
A Structured Program to Encourage Serious Illness Conversations

Dr. Daniela Lamas, BWH, Ariadne Labs

2:05pm - 2:25pm
Care of Caregivers; Boston Pulmonary Fibrosis Support Group
Anne LaFleur, LICSW, MGH
Dr. Katharine Black, MGH

2:25pm - 2:55pm
Audience Questions 

2:55pm - 3:00pm
Closing Remarks